Johnson & Johnson

JNJ-N

NYSE:JNJ

131.13
1.88 (1.41%)
Johnson & Johnson is an American multinational medical devices, pharmaceutical and consumer packaged goods manufacturing company founded in 1886.
More at Wikipedia

Analysis and Opinions about JNJ-N

Signal
Opinion
Expert
BUY
BUY
October 13, 2004
A great company. Feels the US$ will drop so there is a modest exchange risk.
Show full opinionHide full opinion
Johnson & Johnson (JNJ-N)
October 13, 2004
A great company. Feels the US$ will drop so there is a modest exchange risk.
BUY
BUY
September 14, 2004
May be considered boring, but the stability in terms of earnings is going to work well as a theme in the sector.
Show full opinionHide full opinion
Johnson & Johnson (JNJ-N)
September 14, 2004
May be considered boring, but the stability in terms of earnings is going to work well as a theme in the sector.
BUY
BUY
September 8, 2004
Widely diversified product line and not like normal pharmaceutical companies.
Show full opinionHide full opinion
Johnson & Johnson (JNJ-N)
September 8, 2004
Widely diversified product line and not like normal pharmaceutical companies.
TOP PICK
TOP PICK
July 23, 2004
A great business. Low valuation.
Show full opinionHide full opinion
A great business. Low valuation.
TOP PICK
TOP PICK
July 23, 2004
Good ballast for portfolios. Cheap valuation.
Show full opinionHide full opinion
Good ballast for portfolios. Cheap valuation.
TOP PICK
TOP PICK
July 15, 2004
2% yield. Didn't do much over the last year but is starting to recover with different products. On a valuation basis compared to their peers, they are at a much deeper discount. A safe investment.
Show full opinionHide full opinion
2% yield. Didn't do much over the last year but is starting to recover with different products. On a valuation basis compared to their peers, they are at a much deeper discount. A safe investment.
TOP PICK
TOP PICK
July 7, 2004
Pays a little over 2% dividend. A multitude of products. Terrific track record of making money. A safe place to be in uncertain times.
Show full opinionHide full opinion
Pays a little over 2% dividend. A multitude of products. Terrific track record of making money. A safe place to be in uncertain times.
TOP PICK
TOP PICK
May 28, 2004
With the feds tightening and profit growths slowing, the market is going ahead for higher quality stocks. A well-run company and is not expensive.
Show full opinionHide full opinion
With the feds tightening and profit growths slowing, the market is going ahead for higher quality stocks. A well-run company and is not expensive.
BUY
BUY
May 17, 2004
Likes the longer-term outlook for pharmaceuticals. Historically, they have performed relatively well when interest rates are going up.
Show full opinionHide full opinion
Likes the longer-term outlook for pharmaceuticals. Historically, they have performed relatively well when interest rates are going up.
BUY
BUY
May 14, 2004
Health-care sector is the best sector to be in. Can't think of anything better than this stock. Wide range of products.
Show full opinionHide full opinion
Health-care sector is the best sector to be in. Can't think of anything better than this stock. Wide range of products.
DON'T BUY
DON'T BUY
April 20, 2004
Big pharmas have a problem of being too big and gets more leverage through Boston Scientific.
Show full opinionHide full opinion
Big pharmas have a problem of being too big and gets more leverage through Boston Scientific.
TOP PICK
TOP PICK
April 16, 2004
Very high-quality stock.
Show full opinionHide full opinion
Very high-quality stock.
BUY
BUY
April 13, 2004
A great blue-chip company. A wonderful line of consumer products, some good pharmaceuticals and, making money on their coated stent. This stock will not have fast growth.
Show full opinionHide full opinion
A great blue-chip company. A wonderful line of consumer products, some good pharmaceuticals and, making money on their coated stent. This stock will not have fast growth.
TOP PICK
TOP PICK
March 26, 2004
One of his 2 favourite areas is health care because of the demographics. You can buy at a discount to the market.
Show full opinionHide full opinion
One of his 2 favourite areas is health care because of the demographics. You can buy at a discount to the market.
BUY
BUY
March 17, 2004
There is competition in the stent market. The whole health-care sector is a bit of a puzzle. Has been executing very well, but money just doesn't seem to want to flow into health-care.
Show full opinionHide full opinion
There is competition in the stent market. The whole health-care sector is a bit of a puzzle. Has been executing very well, but money just doesn't seem to want to flow into health-care.
Showing 391 to 405 of 444 entries